Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
US9751876B2 · kind B2 · utility
0Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 9, 2014 |
| Grant date | Sep 5, 2017 |
| Priority date | — |
| Expiry date | Oct 9, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Bicyclic heterocyclic derivatives of formula I useful in inhibiting PDGF receptor mediated biological activity.wherein A isand R1, R1a, R2, R3, R4, R5, R6 and X are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.